Skip to content

Emergent Biosolutions EBS Common Stock Shares Issued

Common Stock Shares Issued at other companies

CorMedix logo
CorMedixCRMD
78.4M+15.8%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
41.4M
Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
122M-2.4%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
65.1M+12.0%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Charles River Laboratories logo
Charles River LaboratoriesCRL

Other financials

Income statement

See full
Revenue$156.1M-29.7%
Gross profit$84.1M-37.1%
Operating income$10.5M-79.0%
Net income$6.8M-90.0%
EPS (diluted)$0.07-94.1%

Balance sheet

See full
Cash & equivalents$161.5M+5.7%
Total debt$584.6M-13.1%
Total equity$523.1M-5.4%
Total assets$1.3B-7.4%

Cash flow

See full
Operating cash flow-$33.8M-202%
CapEx$2.4M-33.3%
Free cash flow-$36.2M-145%

Valuation

See full
Market cap$411.74M+22.0%
Enterprise value$834.84M-2.6%
P/E3.6×
P/S0.6×+0.3×

Profitability

See full
Gross margin54.2%+19.0pp
Operating margin15%+10.3pp
Net margin9.6%+5.8pp
FCF margin20.8%

Returns & leverage

See full
Return on equity13.9%+8.1pp
Debt / equity1.1×-0.1×
Current ratio4.3×-2.0×

Where this comes from

Reported directly by Emergent Biosolutions in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's common stock shares issued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Emergent Biosolutions's common stock shares issued?
Emergent Biosolutions (EBS) reported common stock shares issued of 61.4M in Q1 2026.
How has Emergent Biosolutions's common stock shares issued changed year-over-year?
Emergent Biosolutions's common stock shares issued increased by 2.2% year-over-year, from 60.1M to 61.4M.
What is the long-term trend for Emergent Biosolutions's common stock shares issued?
Over 5 years (2020 to 2025), Emergent Biosolutions's common stock shares issued has grown at a 2.4% compound annual growth rate (CAGR), from 54.2M to 60.9M.
What does common stock shares issued mean?
The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.